Unknown

Dataset Information

0

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.


ABSTRACT: Genome-wide association studies (GWAS) of breast cancer defined by hormone receptor status have revealed loci contributing to susceptibility of estrogen receptor (ER)-negative subtypes. To identify additional genetic variants for ER-negative breast cancer, we conducted the largest meta-analysis of ER-negative disease to date, comprising 4754 ER-negative cases and 31 663 controls from three GWAS: NCI Breast and Prostate Cancer Cohort Consortium (BPC3) (2188 ER-negative cases; 25 519 controls of European ancestry), Triple Negative Breast Cancer Consortium (TNBCC) (1562 triple negative cases; 3399 controls of European ancestry) and African American Breast Cancer Consortium (AABC) (1004 ER-negative cases; 2745 controls). We performed in silico replication of 86 SNPs at P ? 1 × 10(-5) in an additional 11 209 breast cancer cases (946 with ER-negative disease) and 16 057 controls of Japanese, Latino and European ancestry. We identified two novel loci for breast cancer at 20q11 and 6q14. SNP rs2284378 at 20q11 was associated with ER-negative breast cancer (combined two-stage OR = 1.16; P = 1.1 × 10(-8)) but showed a weaker association with overall breast cancer (OR = 1.08, P = 1.3 × 10(-6)) based on 17 869 cases and 43 745 controls and no association with ER-positive disease (OR = 1.01, P = 0.67) based on 9965 cases and 22 902 controls. Similarly, rs17530068 at 6q14 was associated with breast cancer (OR = 1.12; P = 1.1 × 10(-9)), and with both ER-positive (OR = 1.09; P = 1.5 × 10(-5)) and ER-negative (OR = 1.16, P = 2.5 × 10(-7)) disease. We also confirmed three known loci associated with ER-negative (19p13) and both ER-negative and ER-positive breast cancer (6q25 and 12p11). Our results highlight the value of large-scale collaborative studies to identify novel breast cancer risk loci.

SUBMITTER: Siddiq A 

PROVIDER: S-EPMC3510753 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.

Siddiq Afshan A   Couch Fergus J FJ   Chen Gary K GK   Lindström Sara S   Eccles Diana D   Millikan Robert C RC   Michailidou Kyriaki K   Stram Daniel O DO   Beckmann Lars L   Rhie Suhn Kyong SK   Ambrosone Christine B CB   Aittomäki Kristiina K   Amiano Pilar P   Apicella Carmel C   Baglietto Laura L   Bandera Elisa V EV   Beckmann Matthias W MW   Berg Christine D CD   Bernstein Leslie L   Blomqvist Carl C   Brauch Hiltrud H   Brinton Louise L   Bui Quang M QM   Buring Julie E JE   Buys Saundra S SS   Campa Daniele D   Carpenter Jane E JE   Chasman Daniel I DI   Chang-Claude Jenny J   Chen Constance C   Clavel-Chapelon Françoise F   Cox Angela A   Cross Simon S SS   Czene Kamila K   Deming Sandra L SL   Diasio Robert B RB   Diver W Ryan WR   Dunning Alison M AM   Durcan Lorraine L   Ekici Arif B AB   Fasching Peter A PA   Feigelson Heather Spencer HS   Fejerman Laura L   Figueroa Jonine D JD   Fletcher Olivia O   Flesch-Janys Dieter D   Gaudet Mia M MM   Gerty Susan M SM   Rodriguez-Gil Jorge L JL   Giles Graham G GG   van Gils Carla H CH   Godwin Andrew K AK   Graham Nikki N   Greco Dario D   Hall Per P   Hankinson Susan E SE   Hartmann Arndt A   Hein Rebecca R   Heinz Judith J   Hoover Robert N RN   Hopper John L JL   Hu Jennifer J JJ   Huntsman Scott S   Ingles Sue A SA   Irwanto Astrid A   Isaacs Claudine C   Jacobs Kevin B KB   John Esther M EM   Justenhoven Christina C   Kaaks Rudolf R   Kolonel Laurence N LN   Coetzee Gerhard A GA   Lathrop Mark M   Le Marchand Loic L   Lee Adam M AM   Lee I-Min IM   Lesnick Timothy T   Lichtner Peter P   Liu Jianjun J   Lund Eiliv E   Makalic Enes E   Martin Nicholas G NG   McLean Catriona A CA   Meijers-Heijboer Hanne H   Meindl Alfons A   Miron Penelope P   Monroe Kristine R KR   Montgomery Grant W GW   Müller-Myhsok Bertram B   Nickels Stefan S   Nyante Sarah J SJ   Olswold Curtis C   Overvad Kim K   Palli Domenico D   Park Daniel J DJ   Palmer Julie R JR   Pathak Harsh H   Peto Julian J   Pharoah Paul P   Rahman Nazneen N   Rivadeneira Fernando F   Schmidt Daniel F DF   Schmutzler Rita K RK   Slager Susan S   Southey Melissa C MC   Stevens Kristen N KN   Sinn Hans-Peter HP   Press Michael F MF   Ross Eric E   Riboli Elio E   Ridker Paul M PM   Schumacher Fredrick R FR   Severi Gianluca G   Dos Santos Silva Isabel I   Stone Jennifer J   Sund Malin M   Tapper William J WJ   Thun Michael J MJ   Travis Ruth C RC   Turnbull Clare C   Uitterlinden Andre G AG   Waisfisz Quinten Q   Wang Xianshu X   Wang Zhaoming Z   Weaver Joellen J   Schulz-Wendtland Rüdiger R   Wilkens Lynne R LR   Van Den Berg David D   Zheng Wei W   Ziegler Regina G RG   Ziv Elad E   Nevanlinna Heli H   Easton Douglas F DF   Hunter David J DJ   Henderson Brian E BE   Chanock Stephen J SJ   Garcia-Closas Montserrat M   Kraft Peter P   Haiman Christopher A CA   Vachon Celine M CM  

Human molecular genetics 20120913 24


Genome-wide association studies (GWAS) of breast cancer defined by hormone receptor status have revealed loci contributing to susceptibility of estrogen receptor (ER)-negative subtypes. To identify additional genetic variants for ER-negative breast cancer, we conducted the largest meta-analysis of ER-negative disease to date, comprising 4754 ER-negative cases and 31 663 controls from three GWAS: NCI Breast and Prostate Cancer Cohort Consortium (BPC3) (2188 ER-negative cases; 25 519 controls of E  ...[more]

Similar Datasets

| S-EPMC5179918 | biostudies-literature
| S-EPMC3910497 | biostudies-literature
| S-EPMC2714974 | biostudies-literature
| S-EPMC3632836 | biostudies-literature
| S-EPMC3653403 | biostudies-literature
| S-EPMC3888264 | biostudies-literature